The complex role of adiponectin in chronic kidney disease
- PMID: 22980197
- DOI: 10.1016/j.biochi.2012.02.024
The complex role of adiponectin in chronic kidney disease
Abstract
Although adiponectin, an adipocytokine released from adipose tissue, is thought to have anti-atherogenic, anti-inflammatory, and insulin-sensitizing effects, it appears that high, rather than low, circulating levels of adiponectin predict increased mortality in chronic kidney disease (CKD) patients in whom the circulating levels may rise to about three times higher than the levels in healthy subjects. As it could be hypothesized that in the uremic milieu high adiponectin levels reflect protein-energy wasting, lower residual renal function and/or volume overload, this may explain, at least in part, the observed paradoxical link between hyperadiponectinemia and poor outcome in CKD. To determine the biological consequences of high circulating adiponectin levels on carbohydrate and insulin metabolism as well as relations with cardiovascular function and mortality in the uremic milieu, further studies need to take into account both high-, and low-molecular weight adiponectin moieties as well as the role of adiponectin receptors. This brief review summarizes some of the recent advances in our understanding of the complex and context-sensitive role of this elusive and intriguing adipokine in the uremic milieu.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Similar articles
-
The role of adiponectin in metabolic and vascular disease: a review.Clin Nephrol. 2011 Jan;75(1):26-33. Clin Nephrol. 2011. PMID: 21176748 Review.
-
Adiponectin in chronic kidney disease: a complex and context sensitive clinical situation.J Ren Nutr. 2011 Jan;21(1):82-6. doi: 10.1053/j.jrn.2010.10.019. J Ren Nutr. 2011. PMID: 21195926 Review.
-
Adiponectin in Chronic Kidney Disease.Int J Mol Sci. 2020 Dec 9;21(24):9375. doi: 10.3390/ijms21249375. Int J Mol Sci. 2020. PMID: 33317050 Free PMC article. Review.
-
Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction.Clin J Am Soc Nephrol. 2007 Jan;2(1):46-50. doi: 10.2215/CJN.02790806. Epub 2006 Nov 29. Clin J Am Soc Nephrol. 2007. PMID: 17699386
-
Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.J Nephrol. 2008 Sep-Oct;21(5):744-52. J Nephrol. 2008. PMID: 18949730
Cited by
-
Exploring Adiponectin in Autosomal Dominant Kidney Disease: Insight and Implications.Genes (Basel). 2024 Apr 11;15(4):484. doi: 10.3390/genes15040484. Genes (Basel). 2024. PMID: 38674417 Free PMC article.
-
Alterations of HDL Particles in Children with End-stage Renal Disease.J Med Biochem. 2017 Oct 28;36(4):358-365. doi: 10.1515/jomb-2017-0019. eCollection 2017 Oct. J Med Biochem. 2017. PMID: 30581333 Free PMC article.
-
Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort.Arthritis Res Ther. 2013;15(6):R210. doi: 10.1186/ar4404. Arthritis Res Ther. 2013. PMID: 24314299 Free PMC article.
-
Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Toxins (Basel). 2017 Mar 23;9(4):114. doi: 10.3390/toxins9040114. Toxins (Basel). 2017. PMID: 28333114 Free PMC article. Review.
-
WAT-on-a-chip: a physiologically relevant microfluidic system incorporating white adipose tissue.Lab Chip. 2017 May 2;17(9):1645-1654. doi: 10.1039/c6lc01590e. Lab Chip. 2017. PMID: 28418430 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials